Amylyx Pharmaceuticals, Inc.

AMLX · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $1.8B · 136 employees
83
SEC Filings
$32.41
Close 2026-09-18
136
Employees

Business Summary

Amylyx Pharmaceuticals is a clinical-stage pharmaceutical company developing novel therapies for endocrine conditions and neurodegenerative diseases. Its lead asset is avexitide, a first-in-class GLP-1 receptor antagonist in Phase 3 (LUCIDITY trial) for post-bariatric hypoglycemia. Additional pipeline includes AMX0035 (Wolfram syndrome, Phase 2), AMX0114 (ALS, Phase 1), and AMX0318 (PBH, preclinical), all targeting high unmet medical needs with no currently approved therapies.

Latest Stock Quote

AMLX 2026-09-18 $32.41 O:$34.21 H:$34.21 L:$32.25 Vol:2.0M VWAP:$32.63
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-11

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-032025-12-310001193125-26-086645EDGAR99K words
2025-03-042024-12-310000950170-25-031309EDGAR98K words
2024-02-222023-12-310000950170-24-018447EDGAR122K words
2023-03-132022-12-310000950170-23-007609EDGAR121K words
2022-03-312021-12-310000950170-22-005157EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001193125-26-336682EDGAR71K words
2025-11-062025-09-300001193125-25-268059EDGAR72K words
2025-08-072025-06-300001193125-25-174948EDGAR70K words
2025-05-082025-03-310000950170-25-066363EDGAR66K words
2024-11-072024-09-300000950170-24-122833EDGAR72K words
2024-08-082024-06-300000950170-24-093311EDGAR70K words
2024-05-092024-03-310000950170-24-056269EDGAR64K words
2023-11-092023-09-300000950170-23-061516EDGAR79K words
2023-08-102023-06-300000950170-23-041335EDGAR77K words
2023-05-112023-03-310000950170-23-021369EDGAR73K words
2022-11-102022-09-300000950170-22-024465EDGAR—
2022-08-112022-06-300000950170-22-016883EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-080001193125-26-385331EDGAR1K words
2026-08-200001193125-26-359418EDGAR21K words
2026-08-180001193125-26-354793EDGAR2K words
2026-08-180001193125-26-354716EDGAR2K words
2026-08-060001193125-26-336670EDGAR3K words
2026-03-240001193125-26-120691EDGAR7K words
2026-03-030001193125-26-086629EDGAR3K words
2026-01-080001193125-26-006991EDGAR7K words
2025-11-060001193125-25-268043EDGAR3K words
2025-09-100001193125-25-200159EDGAR20K words

83 total filings indexed. 56 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

endocrine-conditions neurodegenerative-diseases rare-diseases post-bariatric-hypoglycemia congenital-hyperinsulinism wolfram-syndrome amyotrophic-lateral-sclerosis-(als)

Company Identity

CIK0001658551
TickerAMLX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.amylyx.com
Listed2022-01-07

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 7e9bdbec350ee9adb3086a2aa31e32cff5774edd1c3d2c7e06846a5cebc56b01
parent: 8c80c64e17ada80b60005c5a784666e30e7c3dff8f14d1f7eb9188c9cd134a79
content hash: a9fef87047437013cc5e74a06ecf9aac9487c188a52076c056d51bae27e150a1
signed: 2026-09-29T19:00:14.633Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up AMLX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on AMLX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/AMLX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.